Citations

1. Ellis MJ, et al. (2004). Treatment of metastatic breast cancer. In JR Harris et al., eds., Diseases of the Breast, 3rd ed., pp. 1101–1159. Philadelphia: Lippincott Williams and Wilkins.

2. Ellis MJ, et al. (2000). Treatment of metastatic breast cancer. In JR Harris et al., eds., Diseases of the Breast, 2nd ed., pp. 749–797. Philadelphia: Lippincott Williams and Wilkins.

3. Wood WC, et al. (2005). Malignant tumors of the breast. In VT DeVita Jr et al., eds., Cancer: Principles and Practice of Oncology, 7th ed., vol. 1, pp. 1415–1477. Philadelphia: Lippincott Williams and Wilkins.

4. National Cancer Institute (2006). Probability of breast cancer in American women. National Cancer Institute Fact Sheet. Available online: http://www.cancer.gov/cancertopics/factsheet/Detection/probability-breast-cancer.

5. Weiss RB, et al., (2003). Natural history of more than 20 years of node-positive primary breast carcinoma treated with cyclophosphamide, methotrexate, and fluorouracil-based adjuvant chemotherapy: A study by the Cancer and Leukemia Group B. Journal of Clinical Oncology, 21(9): 1825–1835.

6. Rapiti E, et al. (2006). Complete excision of primary breast tumor improves survival of patients with metastatic breast cancer at diagnosis. Journal of Clinical Oncology, 24(18): 2743–2749.

7. Goss PE, et al. (2003). A randomized trial of letrozole in postmenopausal women after five years of tamoxifen therapy for early-stage breast cancer. New England Journal of Medicine, 349(19): 1793–1802.

8. Coombes RC, et al. (2004). A randomized trial of exemestane after two to three years of tamoxifen therapy in postmenopausal women with primary breast cancer. New England Journal of Medicine, 350(11): 1081–1092.